Production (Stage)
Ernexa Therapeutics Inc.
ERNA
$2.29
-$0.08-3.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.93% | -59.45% | 64.89% | -49.45% | -32.46% |
| Total Receivables | -64.30% | 133.69% | -17.98% | -35.04% | -17.41% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.34% | -33.33% | -63.72% | 10.33% | -56.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.99% | -50.27% | 32.01% | -41.87% | -35.78% |
|
|
|||||
| Total Current Assets | -5.99% | -50.27% | 32.01% | -41.87% | -35.78% |
| Net Property, Plant & Equipment | -9.14% | -8.37% | -97.75% | -1.58% | 11.90% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -1.67% | -97.15% | 0.00% | 0.00% |
| Total Assets | -3.99% | -31.73% | -83.40% | -6.39% | 1.07% |
|
|
|||||
| Total Accounts Payable | -25.92% | -21.52% | 0.00% | 6.30% | 93.35% |
| Total Accrued Expenses | 34.46% | -41.62% | -20.62% | 0.79% | -25.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.90% | 2.99% | -95.29% | 48.43% | 29.69% |
| Total Finance Division Other Current Liabilities | 178,100.00% | -99.67% | -6.30% | 43.41% | 64.63% |
| Total Other Current Liabilities | 178,100.00% | -99.67% | -6.30% | 43.41% | 64.63% |
| Total Current Liabilities | 255.28% | -70.48% | 3.67% | 23.58% | 18.18% |
|
|
|||||
| Total Current Liabilities | 255.28% | -70.48% | 3.67% | 23.58% | 18.18% |
| Long-Term Debt | -- | -- | 260.17% | 10.99% | 18.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.16% | -10.67% | -98.52% | -1.42% | 11.30% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.65% | -98.55% | 2,138.48% | -34.49% | 3.29% |
| Total Liabilities | 208.55% | -93.28% | -3.46% | 3.66% | 13.16% |
|
|
|||||
| Common Stock & APIC | 0.24% | 29.31% | -5.38% | 0.22% | 0.53% |
| Retained Earnings | -3.54% | -2.55% | -13.36% | -2.86% | -3.55% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -450.06% | 103.74% | -432.36% | -149.84% | -252.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -450.06% | 103.74% | -432.36% | -149.84% | -252.91% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -449.79% | 103.75% | -432.41% | -149.88% | -252.80% |
|
|
|||||